sodium arsenite has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, CS; Jun, HS; Kim, S; Lee, EK; Lee, YS; Oh, HH | 1 |
| Ajami, N; Arteel, GE; Barve, S; Massey, VL; Neal, RE; Petrosino, JF; Schmidt, RH; Stocke, KS; Tan, M | 1 |
2 other study(ies) available for sodium arsenite and Obesity
| Article | Year |
|---|---|
Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
Topics: Acetylation; Animals; Arsenites; Biomarkers; Blood Glucose; Body Weight; Cells, Cultured; Diabetes Mellitus, Type 2; Disease Models, Animal; Eating; Energy Metabolism; Forkhead Box Protein O1; Forkhead Transcription Factors; Gluconeogenesis; Glucose-6-Phosphatase; Glycated Hemoglobin; Hepatocyte Nuclear Factor 4; Hypoglycemic Agents; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Phosphoenolpyruvate Carboxykinase (ATP); Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Signal Transduction; Sirtuin 1; Sodium Compounds; Time Factors | 2014 |
Oligofructose protects against arsenic-induced liver injury in a model of environment/obesity interaction.
Topics: Alanine Transaminase; Animals; Arsenites; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cytoprotection; Diet, High-Fat; Disease Models, Animal; Dysbiosis; Inflammation Mediators; Intestines; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Oligosaccharides; Organ Size; Prebiotics; Sodium Compounds; Time Factors | 2015 |